Trade Telix Pharmaceuticals Limited - TLXss CFD

Trading Conditions

• TypeThis financial market is available for CFD trading.Learn more about:CFDs: CFD
• Spread: 0.06
• Long position overnight funding adjustmentLong position overnight funding adjustmentMargin. Your investmentA$1,000.00Overnight funding adjustmentCharges from full value of position-0.023069 %(-A$0.46)Trade size with leverage ~ A$2,000.00Money from leverage ~ A$1,000.00Go to platform: -0.02307%
• Short position overnight funding adjustmentShort position overnight funding adjustmentMargin. Your investmentA$1,000.00Overnight funding adjustmentCharges from full value of position0.001151 %(A$0.02)Trade size with leverage ~ A$2,000.00Money from leverage ~ A$1,000.00Go to platform: 0.00115%
• Overnight funding adjustment time: 21:00 (UTC)
• Currency: AUD
• Min traded quantity: 1
• Margin: 50.00%
• Stock exchange: Australia
• Commission on trade: 0%
• Guaranteed stop premiumA guaranteed stop-loss (GSL) fee is only charged if the GSL is triggered. Please consult the Charges and Fees section of our website for more details.: 1%

• Margin. Your investment: A$1,000.00
• Overnight funding adjustmentCharges from full value of position: -0.023069 %
  (-A$0.46)

• Margin. Your investment: A$1,000.00
• Overnight funding adjustmentCharges from full value of position: 0.001151 %
  (A$0.02)

Key Stats

• Prev. Close: 17.75
• Open: 17.25
• 1-Year Change: 2.68%
• Day's Range: 16.44 - 17.25

Trade Telix Pharmaceuticals Limited - TLXss

What is Telix Pharmaceuticals Limited (TLXss)?

Telix Pharmaceuticals Limited is a biopharmaceutical company engaged in the development and commercialization of molecularly targeted radiopharmaceuticals. Its focus includes diagnostic and therapeutic products that utilize radioactive isotopes to target specific cellular markers associated with diseases such as cancer. Telix Pharmaceuticals develops agents for imaging and treatment, aiming to improve disease detection and patient outcomes through precision medicine approaches. The company's pipeline includes products designed for various oncological indications, leveraging expertise in nuclear medicine and radiochemistry. Operating within the pharmaceutical and biotechnology industries, Telix Pharmaceuticals collaborates with research institutions and healthcare providers to advance its radiopharmaceutical technologies. The company contributes to the evolving field of targeted radiotherapy and diagnostic imaging, addressing unmet medical needs through innovative treatment modalities.

Telix Pharmaceuticals Limited Stock Price Today: Live Overview

The price today is shaped by the latest trading levels, as Portland General Electric Co trades between A$16.41 and A$17.37. It holds a current price of A$16.9 and a daily change of -5.3521%.

FAQ: Telix Pharmaceuticals Limited (TLXss)

What is the current price of TLXss stock?

The current price stands at A$16.9.

Does TLXss pay dividends?

Telix Pharmaceuticals Limited pays dividends via cash distributions (if applicable).

Does TLXss have a formal corporate presence or regional headquarters in the UAE?

Telix Pharmaceuticals Limited has a registered presence in the UAE but no specific office in DIFC or Dubai Internet City.

What is TLXss best known for?

Telix Pharmaceuticals Limited is most famous for its development of molecular diagnostics and radiopharmaceuticals.

What assets are typically shown together with TLXss?

Commonly shown alongside TLXss: ASM Pacific, iShares Russell 1000 Growth UCITS ETF, Aramex PJSC